Tag: Life Science

Managing a Portfolio of Drug Development Projects: How to Find More Certainty in an Uncertain World

The drug development business is fraught with uncertainty.  Unpredictability in discovering and testing new molecular compounds or biologics – ranging from the scientific, operational, financial, regulatory, and organizational – are inherent parts of the process. This article is not about forever-eliminating uncertainty in the drug development process; that will never...

Read More

In case you missed it — Key Take-Aways from our Spring Forum, Eliminating Silos: Enabling Engagement Across the Value Chain

  “Customer centricity”, “patient engagement”, and “patient-focus” are popular buzzwords in the pharmaceutical industry as companies continue to adapt to an ever-evolving customer landscape. So, what’s getting in the way of transforming these businesses to fully embrace a more horizontal, end-to-end approach? TayganPoint Consulting Group hosted a panel with leaders...

Read More

Impact of 21st Century Cures Act

Congress recently passed the 21st Century Cures Act with $4.8 billion dollars in funding and a purpose of speeding the development and approval of new medicines and medical devices the act has generated significant excitement and discussion.  Some of the key components of the legislation include: $4.8 billion dollars additional...

Read More

Archives